AKT1 and specific granule deficiency: Zhou et al. (2023) demonstrated that SGD can inhibit the proliferation of the human gastric adenocarcinoma cell line through the PI3K/AKT signaling pathway. Preliminary studies conducted by our research group have shown that SGD inhibits the proliferation and migration of EESCs and promotes apoptosis (Kuang et al., 2023).